Ibex (IBEX) Q3 2026 earnings review
Unrelenting Top-Line Growth Meets a Transformative AI Partnership
Ibex delivered its fifth consecutive quarter of double-digit revenue growth, beating expectations with a 16.8% YoY acceleration to $164.4M. Net income jumped 27.3% to $13.3M, aided by a strategic mix shift to higher-margin offshore regions. Management matched this financial momentum with a major operational pivot, announcing a landmark partnership with Sierra AI to deploy end-to-end AI customer experiences. The company raised its full-year guidance for the third consecutive quarter. However, the aggressive growth comes at a cost: Adjusted EBITDA margin slightly compressed, and CapEx guidance was hiked significantly to support capacity demands.
🐂 Bull Case
The HealthTech segment is accelerating wildly, posting 53.7% YoY growth in Q3. This builds on a trajectory of 19.5% in Q1 and 35.1% in Q2, proving Ibex is rapidly taking market share in this high-value vertical.
The new partnership with Sierra AI is already paying dividends. Management explicitly stated that deal volume and velocity have accelerated since signing, validating Ibex's pivot toward an AI-first BPO 3.0 model.
🐻 Bear Case
Despite a massive revenue beat and offshore mix shift, Adjusted EBITDA margin slipped 40 bps YoY to 13.4%. The cost of aggressive expansion is beginning to weigh on underlying unit economics.
Management was forced to raise full-year CapEx guidance to $25-$30M. Building out capacity in offshore regions to meet demand is a heavy cash drain, limiting near-term Free Cash Flow generation.
⚖️ Verdict: 🟢
Bullish. The slight margin compression and CapEx hike are acceptable trade-offs for a company consistently delivering mid-teens organic growth, successfully pivoting into AI, and systematically raising guidance quarter after quarter.
Key Themes
HealthTech & Tech Verticals Accelerating
Ibex's pivot toward specialized, high-growth verticals is paying off spectacularly. The HealthTech vertical's growth rate is accelerating aggressively, jumping from 19.5% YoY in 26Q1 to 35.1% in 26Q2, and now reaching 53.7% in 26Q3. The broader Technology vertical also surged 42.6%. This targeted land-and-expand strategy is successfully replacing legacy telecom revenue.
Sierra AI Partnership Driving Deal Velocity
Ibex announced a strategic partnership with Sierra AI to deploy end-to-end, AI-powered CX solutions. This is a critical driver: management noted that sales teams are already seeing both the volume and velocity of deal opportunities accelerate. This moves Ibex from merely using AI internally to selling a highly differentiated, tech-forward product.
Offshore Margin Shift Supporting Net Income
Stable. The continuous shift of capacity to higher-margin offshore regions remains the core driver of bottom-line health. This geographic arbitrage allowed net income margins to expand by 70 bps (to 8.1%) and EPS to grow 21.9%, cleanly offsetting the SG&A infrastructure needed for expansion.
Contradictory Adjusted EBITDA Margin Compression
There is a glaring contradiction in the profitability narrative. Despite 16.8% revenue growth and an explicit shift to higher-margin offshore regions, Adjusted EBITDA margin actually compressed by 40 bps YoY (13.8% to 13.4%). This suggests that the upfront costs of onboarding new clients, technology integration, and facility ramp-ups are structurally dragging down operating leverage.
Capital Intensity Reversing Cash Flow Profile
Accelerating. The cost of growth is becoming highly capital intensive. Management raised full-year CapEx guidance from $20-$25M to $25-$30M to fund high-margin region capacity. For context, FY24 CapEx was only $8.8M, and FY25 was $18.3M. This rapid escalation in fixed asset spending threatens to stifle Free Cash Flow expansion.
Omission of Legacy Laggards
In previous quarters, management explicitly addressed weakness in the FinTech and Telecommunications verticals. In the Q3 release, these segments were conspicuously absent from the growth highlights. Their omission likely indicates that they remain a structural drag on the top line, relying entirely on HealthTech and Tech to carry the load.
Other KPIs
Reversing. FCF bounced back to $6.6M from $3.6M a year ago, and fully reversed the $5.1M FCF outflow experienced in 26Q2. The company generated $11.9M in operating cash flow, successfully absorbing the $5.3M in quarterly CapEx required for global expansion.
Accelerating. Ibex spent $4.5 million on buybacks during the quarter, a sequential step-up from the 78,200 shares ($2.9 million) bought in Q2. This consistent capital return strategy directly contributed to the 21.9% outsized growth in diluted EPS.
Guidance
Accelerating. This is the third consecutive guidance raise this fiscal year. The midpoint of $640M implies a 14.6% YoY growth rate over FY25's $558.3M, indicating that the business is actually growing faster this year than it did last year (9.8%).
Accelerating. Raised from the prior $80M-$82M range. The midpoint of $83M implies a 15.3% YoY growth rate over FY25's $72.0M, effectively keeping pace with the rapid revenue expansion despite the Q3 margin compression.
Accelerating. Raised from the previous $20M-$25M range. Management explicitly tied this to 'ongoing investment to meet increased demand in higher margin regions,' cementing the fact that geographic arbitrage requires heavy upfront cash burn.
Key Questions
Sierra AI Economics
With the Sierra AI partnership accelerating deal velocity, how are the economics of these deals structured? Is this a revenue-share model, and does it carry a fundamentally different margin profile than traditional human-agent contracts?
Margin Contradiction
Adjusted EBITDA margins compressed by 40 basis points this quarter despite a larger mix of high-margin offshore revenue. How much of this compression is structural due to pricing pressure, versus one-time investments in capacity?
CapEx Normalization
Full-year CapEx has been raised to $25-$30 million to chase offshore expansion. At what point does the physical footprint catch up to demand, allowing CapEx as a percentage of revenue to normalize?
Status of Legacy Verticals
We saw great data on HealthTech and Tech, but Telecommunications and FinTech were historically lagging. Have these legacy verticals stabilized, or are they still experiencing double-digit declines?